Cyclo Therapeutics Inc.

NAS: CYTH

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Jan 21, 2022, 8:46 a.m.

/zigman2/quotes/207006339/composite

$

3.85

Change

+0.01 +0.26%

Volume

Volume 454

Real time quotes

/zigman2/quotes/207006339/composite

Previous close

$ 3.84

$ 3.84

Change

-0.20 -4.95%

Day low

Day high

$3.83

$4.20

Open

52 week low

52 week high

$3.43

$17.75

Open

Annual Financials for Cyclo Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 1.5M1.24M1.01M1.01M903,376
Cost of Goods Sold (COGS) incl. D&A 1.58M1.33M1.29M1.99M2.64M
COGS excluding D&A 1.47M1.32M1.28M1.98M2.63M
Depreciation & Amortization Expense 107,0969,27110,1245,68112,763
Depreciation 107,0969,27110,1245,68112,763
Amortization of Intangibles -----
Gross Income (76,930)(87,874)(275,614)(980,414)(1.74M)
20162017201820192020 5-year trend
SG&A Expense 3.27M3.75M3.98M6.41M7.22M
Research & Development 1.86M2.29M2.71M4.87M6.1M
Other SG&A 1.4M1.46M1.27M1.54M1.13M
Other Operating Expense 5,0005,50012,150153,770-
Unusual Expense 810,000----
EBIT after Unusual Expense (4.16M)----
Non Operating Income/Expense (48,670)2,820---
Non-Operating Interest Income 10,64910,26111,77312,02719,802
Equity in Affiliates (Pretax) -----
Interest Expense 28,603----
Gross Interest Expense 28,603----
Interest Capitalized -----
Pretax Income (4.22M)(3.83M)(4.26M)(7.53M)(8.94M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (4.22M)(3.83M)(4.26M)(7.53M)(8.94M)
Minority Interest Expense -----
Net Income (4.22M)(3.83M)(4.26M)(7.53M)(8.94M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (4.22M)(3.83M)(4.26M)(7.53M)(8.94M)
Preferred Dividends -----
Net Income Available to Common (4.22M)(3.83M)(4.26M)(7.53M)(8.94M)
EPS (Basic) (7.00)(5.00)(0.05)(6.96)(5.59)
Basic Shares Outstanding 633,545720,37281.76M1.08M1.6M
EPS (Diluted) (7.00)(5.00)(0.05)(6.96)(5.59)
Diluted Shares Outstanding 633,545720,37281.76M1.08M1.6M
EBITDA (3.24M)(3.84M)(4.26M)(7.54M)(8.95M)
Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.